Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ANP Technologies
Newark, Delaware, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
ANP Technologies is a clinical stage biopharmaceutical company with proprietary nano-encapsulating polymer-based drug delivery technology, tested in clinical trials (e.g., with FID-007 for solid tumors) and with IND-stage or clinical pipelines in oncology and infectious disease. Their platform has demonstrated safety and promising pharmacokinetic improvements in human studies[4][5][6].
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small moleculeProteinNanoencapsulated drug deliveryPolymeric drug deliveryAntibodyMonoclonal antibody
- Industry
- Biotech
02
Partnerships
Celgene/Bristol Myers SquibbFulgent PharmaU.S. Department of Defense
Beyond the preview
Go deeper on ANP Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ANP Technologies.